United States · FDA National Drug Code directory
Nizatidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-311_254e5866-1ba8-8d97-bc03-19916119ff87
- Product NDC
- 55111-311
- Form
- CAPSULE
- Composition / generic term
- Nizatidine
- Labeler
- Dr Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050915
- Source listing expiry
- 20261231
Source-listed ingredients
- NIZATIDINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (55111-311-01) · 55111-311-01
- 500 CAPSULE in 1 BOTTLE (55111-311-05) · 55111-311-05
- 30 CAPSULE in 1 BOTTLE (55111-311-30) · 55111-311-30
- 60 CAPSULE in 1 BOTTLE (55111-311-60) · 55111-311-60
- 10 BLISTER PACK in 1 CARTON (55111-311-78) / 10 CAPSULE in 1 BLISTER PACK (55111-311-79) · 55111-311-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →